MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$36,802K
EPS
-$0.16
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Selling, general and administrative
-
-
7,610
7,809
Revenue
406
495
753
301
Cost of goods sold
1,231
2,038
260
213
Research and development
18,144
19,462
17,273
22,006
General and administrative
8,027
7,930
-
-
Total operating expenses
27,402
29,430
25,143
30,028
Loss from operations
-26,996
-28,935
-24,390
-29,727
Interest income
388
330
590
832
Interest expense
2,321
2,271
2,612
2,545
Change in fair value of contingent earnout liability
2,718
-4,732
-4,893
5,470
Change in fair value of derivatives
-5,155
8,525
4,009
-748
Total other (expense) income, net
-9,806
11,316
6,880
-7,931
Net (loss) income and comprehensive (loss) income
-36,802
-17,619
-17,510
-37,658
Basic EPS
-0.16
-0.09
-0.11
-0.24
Diluted EPS
-0.16
-0.09
-0.11
-0.24
Basic Average Shares
234,182,284
197,846,786
158,313,290
155,437,281
Diluted Average Shares
234,182,284
197,846,786
158,313,290
155,437,281
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Product
$406K
(306.00%↑ Y/Y)
Net (loss) income
and comprehensive...
-$36,802K
(2.27%↑ Y/Y)
Product
$406K
(306.00%↑ Y/Y)
Loss from operations
-$26,996K
(9.19%↑ Y/Y)
Total other (expense)
income, net
-$9,806K
(-23.64%↓ Y/Y)
Revenue
$406K
(34.88%↑ Y/Y)
Interest income
$388K
(-53.37%↓ Y/Y)
Total operating
expenses
$27,402K
(-8.75%↓ Y/Y)
Change in fair value of
derivatives
-$5,155K
(-589.17%↓ Y/Y)
Change in fair value of
contingent earnout...
$2,718K
(-50.31%↓ Y/Y)
Interest expense
$2,321K
(-8.80%↓ Y/Y)
Research and development
$18,144K
(-17.55%↓ Y/Y)
General and
administrative
$8,027K
Cost of goods sold
$1,231K
(477.93%↑ Y/Y)
Buy us a coffee
Humacyte, Inc. (HUMA)
Humacyte, Inc. (HUMA)